Influencing factors of adherence to prophylaxis in adults with hemophilia: A qualitative study
Abstract
Keywords
References
- Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, et al. Haemophilia. Nat Rev Dis Primers. 2021;7(1):45.
- Hermans C, Noone D, Benson G, Dolan G, Eichler H, Jiménez-Yuste V, et al. Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev. 2022;52:100890.
- Malec L, Matino D. Targeting higher factor VIII levels for prophylaxis in haemophilia A: a narrative review. Haemophilia. 2023;29(6):1419-29.
- Cotino C, Pérez-Alenda S, Cruz-Montecinos C, López-Bueno R, Núñez-Cortés R, Suso-Martí L, et al. Barriers and facilitators of physical activity in adults with severe haemophilia: A qualitative study. Haemophilia. 2023;29(5):1334-42.
- Sun J, Zhou X, Hu N. Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review. Orphanet J Rare Dis. 2021;16(1):287.
- Guasch S, Scott LC, Figueroa J, Buckner TW, Mattis S, Tran DQ, Jr., et al. Cross-sectional study evaluating the association of haemophilia-related distress and clinically relevant outcomes. Haemophilia. 2023;29(2):505-12.
- Mokhtar FM, Sathar J, Huri HZ. Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention. Healthcare (Basel). 2021;9(12).
- Cheung YT, Lam PH, Lam HHW, Ma CT, Leung AWK, Wong RSM, et al. Treatment Adherence and Health-Related Quality of Life in Patients with Hemophilia in Hong Kong. Int J Environ Res Public Health. 2022;19(11).
Details
Primary Language
English
Subjects
Haematology, Internal Diseases
Journal Section
Research Article
Authors
Zühal Demirci
*
0000-0001-7509-8020
Türkiye
Yasemin Yıldırım
0000-0002-8970-3743
Türkiye
Fahri Şahin
0000-0001-9315-8891
Türkiye
Publication Date
June 10, 2026
Submission Date
March 16, 2025
Acceptance Date
December 16, 2025
Published in Issue
Year 2026 Volume: 65 Number: 2